Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Animal research suggests perimenopause is a critical time for women’s health

06.12.2005


Research in monkeys suggests that the perimenopause – the five to 10 years before a woman’s menopause – is a critical time for preventing heart disease and osteoporosis.



"Research in animals suggests that the five years before menopause are when bone is lost and when heart vessel disease begins to accelerate," according to Jay Kaplan, Ph.D., from Wake Forest University Baptist Medical Center, who spoke today at the annual meeting of the American College of Veterinary Pathologists in Boston. "Waiting until menopause is not the time to start thinking about prevention."

Kaplan, a professor of comparative medicine, was invited to summarize his extensive research on how hormone levels affect health. His work has focused primarily on how stress during the younger years can interfere with ovulation and reduce estrogen levels, which can set the stage for heart disease later in life.


"But, this isn’t just a problem in younger women," he said. "At perimenopause, all women are affected by variably changing and ultimately declining estrogen levels. Perimenopause is a time of increased vulnerability to chronic disease."

Women have traditionally been considered immune from heart disease until after menopause, when their estrogen levels dramatically drop. However, Kaplan’s research has shown that in monkeys, the process starts much earlier. He found that stress in the younger years can reduce estrogen levels and lead to the buildup of fatty deposits in the blood vessels (atherosclerosis) that can lead to heart attacks and strokes.

"Our research adds to the growing body of evidence that cardiovascular health after menopause is influenced by hormone levels many years earlier," said Kaplan. "Our monkey studies showed that a deficiency of estrogen before menopause places these females on a high-risk trajectory, even if they got estrogen treatment after menopause."

For women in perimenopause who intend to take hormone therapy, Kaplan said the research suggests that perimenopause may be the best time to start.

"The results emphasize that primary prevention of heart disease should start pre-menopausally," he said.

Kaplan’s animal studies found that treating the estrogen-deficient monkeys with estrogen before menopause markedly slowed the growth of atherosclerosis. Kaplan said the findings were consistent with the hypothesis that estrogen inhibits the development of vessel disease, but may be ineffective if the disease already exists.

"Applied to women, this lifetime study suggests that having an estrogen deficiency in the pre-menopausal years predicts a higher rate of heart disease after menopause, even when treated with hormone replacement therapy after menopause," said Kaplan.

Kaplan said that some physicians advocate women taking oral contraceptives right up until menopause, and then beginning hormone therapy. He said animal research suggests that oral contraceptives can be effective in heart disease protection.

However, the Women’s Health Initiative, the largest study to date to test the effectiveness of hormone therapy in women, found that treatment with combination therapy (estrogen and progestin) increased risk of breast cancer, heart attacks and stroke. As a result of the study, many doctors advise that women not take hormone therapy to prevent heart disease.

But critics of that study say it didn’t involve enough younger women to see if taking the drugs earlier can be effective for prevention. A theory that there is a "window of opportunity" for hormone therapy to be effective for prevention is being tested in a five-year study of peri-menopausal women ages 45 to 54. Funded by the Kronos Longevity Research Institute, the study is evaluating an oral tablet containing estrogen, a skin patch delivering estrogen and a placebo.

Karen Richardson | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>